Rigel Pharmaceuticals, Inc. (RIGL)
25.96
-0.14
(-0.54%)
USD |
NASDAQ |
Mar 20, 16:00
25.99
+0.03
(+0.12%)
After-Hours: 20:00
Rigel Pharmaceuticals EPS Diluted (Quarterly) : 13.54 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Nektar Therapeutics | -1.778 |
| Ironwood Pharmaceuticals, Inc. | -0.014 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Amicus Therapeutics, Inc. | 0.0054 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 268.06M |
| Revenue (Quarterly) | 69.80M |
| Total Expenses (Quarterly) | -198.26M |
| Enterprise Value | 377.91M |
| Gross Profit Margin (Quarterly) | 91.47% |
| Earnings Yield | 72.85% |
| Operating Earnings Yield | 25.68% |
| Normalized Earnings Yield | 72.85 |